Akamai Technologies, Inc. (AKAM) Stock Price Today
Key Stats
- $17.27BMarket Cap
- -Volume
- TechnologySector
- $161.1452W High
- $70.5352W Low
- -Typical Hold Time
- $22.21BEnterprise Value
- -Div Yield
- -Trading Activity
Track Akamai Technologies, Inc. (AKAM) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Akamai Technologies, Inc. has traded between a low of $70.53 and a high of $161.14, highlighting its annual price range. Buy and sell Akamai Technologies, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Akamai Technologies, Inc.
Akamai operates a content delivery network, or CDN, which entails locating servers at the edges of networks so its customers, which store content on Akamai servers, can reach their own customers faster, more securely, and with better quality. Akamai has over 325,000 servers distributed over 4,000 points of presence in more than 1,000 cities worldwide. Its customers generally include media companies, which stream video content or make video games available for download, and other enterprises that run interactive or high-traffic websites, such as e-commerce firms and financial institutions. Akamai also has a significant security business, which is integrated with its core web and media businesses to protect its customers from cyberthreats.
Most Recent News
Pinterest co-founder sells $2.1M in stock amid 37% share price drop
The co-founder of Pinterest has sold $2.1 million worth of company stock while the share price has fallen by 37%. This sale highlights insider activity during a period of significant stock decline, which may concern investors about the company's near...
NCLA urges Supreme Court to review vaccine mandate rulings misapplying Jacobson precedent
The New Civil Liberties Alliance (NCLA) has filed a brief urging the U.S. Supreme Court to hear a case challenging Covid-19 vaccine mandates imposed by Oregon and PeaceHealth. The mandates required healthcare workers to receive the Pfizer-BioNTech va...
Clariant rejects Dow Europe's €1.1B damage claim over 2020 competition law case.
Clariant has firmly denied Dow Europe's claim for €1.1 billion in damages related to a 2020 competition law infringement on the ethylene purchasing market, which was sanctioned by the European Commission. The claim was filed in a German court on July...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.